» Articles » PMID: 16908619

Olfactory Disorder in Children with 22q11 Deletion Syndrome

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2006 Aug 16
PMID 16908619
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: 22q11 deletion syndrome, a common human interstitial deletion syndrome (1:5000), is associated with a heterogeneous physical phenotype, including several factors that markedly increase the risk for olfactory disorder. Despite its potential consequences, pediatric studies of impaired olfaction are rare, and odor detection in children with 22q11 deletion syndrome has not yet been examined.

Methods: The University of Pennsylvania Smell Identification Test was administered to 62 children, including 39 with 22q11 deletion syndrome and 23 neurotypical control siblings who ranged in age from 5.3 to 14.8 years. Lowered smell detection accuracy among affected children was predicted.

Results: Substantially more children with 22q11 deletion syndrome (68%) as compared with neurotypical control subjects (13%) had University of Pennsylvania Smell Identification Test scores > or = 2 SDs below the standardization sample mean. Frequency of impairment in younger versus older children did not differ. The score distributions of children with and without velopharyngeal insufficiency did not differ; however, markedly lower score variance among children with velopharyngeal insufficiency suggested its negative impact on olfaction. Posthoc error analyses revealed that affected children had special difficulty detecting smells that are associated with fumes and smoke.

Conclusions: Odor detection failures are ubiquitous among children with 22q11 deletion syndrome and are not associated with developmental delay or performance characteristics of younger affected children. Additional studies are needed to examine further the impact on olfaction of velopharyngeal insufficiency and compromised nasal airway patency. Children with 22q11 deletion syndrome should be evaluated routinely for olfactory disorder. When deficits are identified, caregivers should be warned of potential dangers that are associated with this type of sensory impairment.

Citing Articles

Inflammation and olfactory loss are associated with at least 139 medical conditions.

Leon M, Troscianko E, Woo C Front Mol Neurosci. 2024; 17:1455418.

PMID: 39464255 PMC: 11502474. DOI: 10.3389/fnmol.2024.1455418.


Olfactory loss is a predisposing factor for depression, while olfactory enrichment is an effective treatment for depression.

Leon M, Woo C Front Neurosci. 2022; 16:1013363.

PMID: 36248633 PMC: 9558899. DOI: 10.3389/fnins.2022.1013363.


Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.

Tang S, Moberg P, Yi J, Wiemken A, Dress E, Moore T Schizophr Res. 2018; 202:113-119.

PMID: 30007867 PMC: 6432914. DOI: 10.1016/j.schres.2018.07.012.


Spectrum of Clinical and Associated MR Imaging Findings in Children with Olfactory Anomalies.

Booth T, Rollins N AJNR Am J Neuroradiol. 2016; 37(8):1541-8.

PMID: 26988815 PMC: 7960283. DOI: 10.3174/ajnr.A4738.


Evidence of olfactory deficits as part of the phenotypic spectrum of nonsyndromic orofacial clefting.

May M, Sanchez C, Deleyiannis F, Marazita M, Weinberg S J Craniofac Surg. 2014; 26(1):84-6.

PMID: 25534055 PMC: 4289083. DOI: 10.1097/SCS.0000000000001242.


References
1.
Gerdes M, Solot C, Wang P, Moss E, LaRossa D, Randall P . Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet. 1999; 85(2):127-33. View

2.
Macfarlane A . Olfaction in the development of social preferences in the human neonate. Ciba Found Symp. 1975; (33):103-17. DOI: 10.1002/9780470720158.ch7. View

3.
Hawkes C, Shephard B, Daniel S . Is Parkinson's disease a primary olfactory disorder?. QJM. 2000; 92(8):473-80. DOI: 10.1093/qjmed/92.8.473. View

4.
Berkowicz D, Trombley P . Dopaminergic modulation at the olfactory nerve synapse. Brain Res. 2000; 855(1):90-9. DOI: 10.1016/s0006-8993(99)02342-2. View

5.
Murphy K, Owen M . Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. Br J Psychiatry. 2001; 179:397-402. DOI: 10.1192/bjp.179.5.397. View